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Abstract
Background: Impaired coronary vasodilation to both endothelial-dependent and endothelial-
independent stimuli have been associated with atherosclerosis. Direct measurement of coronary
vasodilation using x-ray angiography or intravascular ultrasound is invasive and, thus, not
appropriate for asymptomatic patients or for seria l  f o l l o w - u p .  I n  t h i s  study, high-resolution
coronary cardiovascular magnetic resonance (CMR) was used to investigate the vasodilatory
response to nitroglycerine (NTG) of asymptomatic patients at high risk for CAD.
Methods: A total of 46 asymptomatic subjects were studied: 13 high-risk patients [8 with diabetes
mellitus (DM), 5 with end stage renal disease (ESRD)] and 33 age-matched controls. Long-axis and
cross-sectional coronary artery images were acquired pre- and 5 minutes post-sublingual NTG
using a sub-mm-resolution multi-slice spiral coronary CMR sequence. Coronary cross sectional
area (CSA) was measured on pre- and post-NTG images and % coronary vasodilation was
calculated.
Results: Patients with DM and ESRD had impaired coronary vasodilation to NTG compared to
age-matched controls (17.8 ± 7.3% vs. 25.6 ± 7.1%, p = 0.002). This remained significant for ESRD
patients alone (14.8 ± 7.7% vs. 25.6 ± 7.1%; p = 0.003) and for DM patients alone (19.8 ± 6.3% vs.
25.6 ± 7.1%; p = 0.049), with a non-significant trend toward greater impairment in the ESRD vs.
DM patients (14.8 ± 7.7% vs. 19.8 ± 6.3%; p = 0.23).
Conclusion: Noninvasive coronary CMR demonstrates impairment of coronary vasodilation to
NTG in high-risk patients with DM and ESRD. This may provide a functional indicator of subclinical
atherosclerosis and warrants clinical follow up to determine prognostic significance.
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Background
Impaired vasodilation is an early marker of atherosclero-
sis [1-4]. Although abnormal response to endothelial-
dependent stimuli is more commonly associated with cor-
onary artery disease (CAD) [3,5-8], several studies have
associated impaired vasodilatory response to nitroglyc-
erin (NTG) with risk factors for coronary artery disease [9]
and increased future clinical events [6,10]. Previous stud-
ies, however, have used x ray angiography [3-8] and intra-
vascular ultrasound [11] which are invasive and, thus, not
appropriate for asymptomatic patients or serial follow-up.
A non-invasive measure of subclinical coronary athero-
sclerosis may help identify patients who are at increased
risk and guide therapy toward reducing morbidity and
mortality. We and others have previously developed a
non-invasive method to measure NTG-induced coronary
vasodilation with coronary cardiovascular magnetic reso-
nance (CMR) [12,13]. We hypothesize that impaired cor-
onary vasodilation to NTG can be demonstrated
noninvasively in asymptomatic patients at increased risk
for coronary artery disease.
Methods
Subjects
Asymptomatic patients with diabetes mellitus (DM, N =
8) and end stage renal disease (ESRD, N = 5), as well as
age-matched controls (N = 33) were recruited consecu-
tively. Subjects were excluded if they had a history of chest
pain, coronary artery disease, myocardial infarction,
stroke or peripheral vascular disease. Vasoactive medica-
tions were discontinued 24 hours before the examination.
All subjects provided written informed consent approved
by the Human Subjects Committee at Stanford University.
CMR
A 1.5-T Signa MRI scanner (GE Healthcare, Milwaukee,
Wisconsin) equipped with high-performance gradients
(40 mT/m, 150 mt/m/ms) and a real-time interactive
workstation were used. A commercial coil provided signal
reception (5-inch General Purpose Coil, Model
#2127316, GE Healthcare, Milwaukee, Wisconsin). Blood
pressure and heart rate were monitored throughout the
study (Omega 1400, In vivo Research, Inc., Orlando, Flor-
ida).
Protocol
NTG-induced coronary vasodilation was performed as
previously described [13]. A real-time interactive MR sys-
tem [13-15] was used to localize coronary arteries (16
frames/sec, TR 4.6 ms, flip 30, slice thickness 7 mm, FOV
24 cm, in-plane resolution 2.7 mm). High-resolution cor-
onary MRA was then performed using a cardiac-gated,
breath-held, multi-slice spiral sequence [13] (FOV = 20–
28 cm, slice thickness = 5 mm, TR = 1 heartbeat, TE = 7 ms,
in-plane spatial resolution = 0.62–0.99 mm, 14 to 20
interleaves, flip angle = 60 degrees, acquisition gated to
diastole). In-plane and cross-sectional images were
acquired before and then 5 minutes after 0.4 mg sublin-
gual NTG, which was given while the subject was in the
magnet. Images were reconstructed onto a 512 × 512
matrix, yielding a pixel size of 0.39 to 0.55 mm. Real-time
short axis views of the left ventricle (LV) from the apex to
base as well as 4-, 3- and 2-chamber views were also
obtained to evaluate LV function.
Image Analysis
For quantitative analysis of coronary vasodilation, the
cross-sectional right coronary artery (RCA) images were
used, except in subjects with a small non-dominant RCA,
where the cross-sectional left anterior descending artery
(LAD) images (n = 5) were used. As described previ-
ously[13] the slice with the most circular cross-section was
identified on the pre-NTG images and the corresponding
post-NTG slice was carefully matched according to the
surrounding cardiac and chest wall structures. These
images were then pooled and randomized, with no
patient information or NTG status provided on the
images, and then analyzed independently and in a
blinded fashion by one observer. A custom designed soft-
ware program was used to analyze the cross sectional
images: after images were magnified two-fold, an ovoid
region of interest tool was used to trace around the RCA
or LAD, yielding the cross-sectional area (CSA). This anal-
ysis has been shown previously to have a low intra- and
inter-observer variability [12,13] and good correlation
with x-ray coronary angiography [13].
Statistical Analysis
Data were expressed as mean values ± standard deviation.
The difference in coronary artery size before and after NTG
was compared by a paired two-sided t test. Differences in
% coronary vasodilation between patients and controls
were tested using an unpaired two-sided t test. Differences
among subject groups were tested using a one-way analy-
sis of variance (ANOVA) and Fisher exact test. All statisti-
cal analyses were performed with StatView (version 5, SAS
Institute Inc., Cary, NC).
Results
Clinical characteristics of the patient and control groups
are shown in Table 1. All 46 subjects completed the study
without complications. NTG caused a small systemic
effect: 9.1 ± 8.5% decrease in systolic blood pressure, 3.2
± 6.7% decrease in diastolic blood pressure, and 5.4 ±
7.7% increase in heart rate, which was not different
between patients and controls (Table 1). The mean age of
the patients and controls was similar (patients: 55.3 ±
14.3 yrs, controls: 51.8 ± 10.4 yrs, p = 0.4); however, the
sex difference was significant (patients: 92% male, con-
trols: 48% male, p = 0.006). Patients with DM and ESRDJournal of Cardiovascular Magnetic Resonance 2008, 10:28 http://www.jcmr-online.com/content/10/1/28
Page 3 of 7
(page number not for citation purposes)
had a higher incidence of hypertension and use of angi-
otensin converting enzyme inhibitors (p = 0.001). One
control subject was excluded from analysis because of
abnormal left ventricular function. No subjects needed to
be excluded because of image quality.
Coronary CMR detected a significant increase in coronary
CSA with NTG in both patients and controls (p < 0.0001
for both), but the degree of coronary artery vasodilation to
NTG was significant impaired in patients compared to
controls (17.8 ± 7.3% vs. 25.6 ± 7.1%, p = 0.002, Figures
1, 2, 3). This % vasodilation in controls was similar to that
of our prior study (24.0%) [13]. Analysis by patient sub-
group was also significant (ANOVA p = 0.005, Figure 3b),
with ESRD patient alone vs. controls (14.8 ± 7.7% vs. 25.6
± 7.1%; Fisher exact test p = 0.003) and DM patients alone
vs. controls (19.8 ± 6.3% vs. 25.6 ± 7.1%; Fisher exact test
p = 0.049) showing impaired coronary vasodilation.
There was a non-significant trend toward greater impair-
ment in the ESRD vs. DM patients (14.8 ± 7.7% vs. 19.8 ±
6.3%; Fisher exact test p = 0.23).
Given the disparity in gender distribution between the
patients and controls, we analyzed by gender. The impair-
ment of coronary vasodilation remained significant in
male patients vs. male controls (18.3 ± 7.4% vs. 27.6 ± 5.7
%, p = 0.002). The lack of females in the patient group
precluded comparing female patients to controls.
Comparing RCA and LAD, there were not significant dif-
ferences in baseline CSA (RCA: 16.3 ± 4.2 mm2 vs. LAD:
14.7 ± 2.6 mm2, p = 0.31) or coronary vasodilation (RCA:
23.5 ± 7.9% vs. LAD: 22.2 ± 8.2%, p = 0.77).
Discussion
In the present study, noninvasive coronary CMRA demon-
strated impaired coronary artery vasodilation to NTG in a
group of patients at increased risk for coronary artery dis-
ease. To our knowledge, this is the first study to use nonin-
vasive imaging to directly assess impaired epicardial
coronary vasodilation in this patient group.
Coronary Vasomotor Function and Atherosclerosis
Abnormal coronary vasomotor function occurs early in
the development of atherosclerosis [16] and is typically
assessed by studying endothelial-dependent epicardial cor-
onary vasodilation by invasive methods [5,17]. However,
several x-ray coronary angiography studies [6,10] have
also found impairment of endothelial-independent coro-
nary vasodilation to NTG in patients, with prognostic sig-
Coronary CMR of a control subject showing coronary  vasodilation: In plane pre-NTG (a) and post-NTG (b) and  cross-sectional pre-NTG (c) and post-NTG (d) images of the  proximal right coronary artery (arrows) Figure 1
Coronary CMR of a control subject showing coronary 
vasodilation: In plane pre-NTG (a) and post-NTG (b) and 
cross-sectional pre-NTG (c) and post-NTG (d) images of the 
proximal right coronary artery (arrows).
Table 1: Baseline characteristics of study subjects
Characteristics Controls (n = 33) Patients with DM or ESRD (n = 13) P value
Age (years) 51.8 ± 10.4 55.3 ± 14.3 0.4
Male 16/33 12/13 0.006
HTN 9/33 9/13 0.02
FH 6/33 5/13 0.15
Dyslipidemia 4/33 4/13 0.13
ACE-I 2/33 6/13 0.001
Current smoker 1/33 1/13 0.49
Decrease in SBP (mmHg) 9.2 ± 7.0% 9.0 ± 11.5% 0.97
Decrease in DBP (mmHg) 3.7 ± 7.0% 2.0 ± 5.5% 0.45
Increase in HR (beats/min) 5.5 ± 7.9% 5.2 ± 7.2% 0.89
Results are given as mean ± standard deviation or proportions. HTN: hypertension; FH: family history; ACE-I: angiotensin converting enzyme 
inhibitor; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rateJournal of Cardiovascular Magnetic Resonance 2008, 10:28 http://www.jcmr-online.com/content/10/1/28
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nificance. In a study of 147 patients with risk factors for
CAD (including 9% with diabetes and 84% with angio-
graphic evidence of atherosclerosis) followed for a
median 7.7 years, abnormal vasodilator response to acety-
choline, cold pressor, and NTG were each independently
associated with disease progression and increased cardio-
vascular events [6]. Consistent with these findings, a study
of 163 women (including 26% with diabetes and 45%
without angiographic evidence of CAD) found impaired
reactivity to NTG and acetycholine in subjects who had
future cardiovascular events [10].
Comparison of the percent coronary vasodilation in all subjects: a) Compared to controls, patients had significantly impaired  vasodilation Figure 3
Comparison of the percent coronary vasodilation in all subjects: a) Compared to controls, patients had significantly impaired 
vasodilation. b) Patient subgroup analysis: Endstage renal disease (ESRD) patients and diabetes (DM) patients both had signifi-
cantly impaired vasodilation compared to controls. Individual subjects with vasodilation < 15% indicated in red. * – p < 0.05 vs. 
controls, ** – p < 0.005 vs. controls.
Coronary CMR of a patient with end stage renal disease showing no significant coronary vasodilation: Cross-sectional pre- NTG (a) and post-NTG (b) images of the proximal right coronary artery Figure 2
Coronary CMR of a patient with end stage renal disease showing no significant coronary vasodilation: Cross-sectional pre-
NTG (a) and post-NTG (b) images of the proximal right coronary artery.Journal of Cardiovascular Magnetic Resonance 2008, 10:28 http://www.jcmr-online.com/content/10/1/28
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Impaired Coronary Vasomotor Function and Patients with 
DM and ESRD
Prospective data on coronary vasomotor function are lim-
ited in patients with DM [18] and ESRD [19]. However,
consistent with an increased cardiovascular risk, peripheral
vasomotor dysfunction has been almost universally
found in these patients [20-26]. Two studies in non-insu-
lin-dependent DM have shown impaired brachial artery
vasodilation to both endothelial-dependent and endothe-
lial-independent stimuli [24,26]. Interestingly, in a study
using brachial ultrasound in subjects with no docu-
mented CAD (including 13.1% with DM), the only risk
factor independently associated with impaired NTG-
induced vasodilation was DM [27]. Similar to findings in
the peripheral vasculature, reduced coronary artery reac-
tivity to NTG has been previously reported in patients
with DM. In a study [9] of non-insulin-dependent DM
using intravascular ultrasound, coronary artery distensi-
bility and diastolic cross sectional luminal area after NTG
were significantly lower in DM compared to controls.
Similar to patients with DM, patients with renal failure
have impaired peripheral vasomotor function [19,28,29].
In a study of 28 patients with chronic renal failure (13 on
hemodialysis), both flow-mediated and NTG-induced
brachial artery vasodilation were impaired to comparable
degrees [28]. To date, there are no known studies on cor-
onary vasoreactivity in patients with ESRD.
Our data show that patients with DM and ESRD have
impaired NTG-induced coronary vasodilation compared
to age-matched controls. The individual data (Figure 3b)
reveal that patients generally fell into two groups: those
with normal coronary vasodilation (~25%) and those
with low coronary vasodilation (< 15%). Eighty percent
(80%) of ESRD and 38% of DM patients fell below the
15% threshold, compared to only 6% of the controls.
Noninvasive Coronary Imaging
CMR [30,31], computed tomography (CT) [32,33], ultra-
sound [34-36], and nuclear techniques [37,38] all offer
alternative approaches to assess coronary artery disease
noninvasively. By using sub-mm spatial resolution and
analyzing the lumen cross-sectional area, CMR has been
shown to have adequate resolution to detect coronary
vasodilation to NTG in two prior studies [12,13]. CMR
can also directly image the coronary wall, with increased
wall thickness demonstrated in patients with Type I DM
[39] and non-obstructive CAD [39,40]. CT can provide
high-resolution structural imaging of the coronary lumen
and wall [32], but the radiation and contrast involved
make it suboptimal for serial imaging of coronary vaso-
motor changes. One recent study did look retrospectively
at patients who had more than one coronary CT scan,
where NTG was used in one and not in another, and did
show significantly larger coronary diameter with NTG
[41]. The feasibility of transthoracic echocardiography for
measuring epicardial coronary vasodilation has recently
been shown in healthy men [42]. The other main
approach to assess coronary function noninvasively has
been to measure coronary flow or perfusion reserve to a
vasodilator stimulus (e.g., adenosine). This is primarily a
measure of coronary microvascular function in the absence
of epicardial stenoses. This can be performed by CMR
[30,31,43], positron emission tomography (PET) [37,38],
and transthoracic Doppler techniques [34-36] and has
been shown to be impaired in patients with coronary risk
factors [31,38], including DM[35,38]. More data compar-
ing the prognostic significance of epicardial vs. microvas-
cular vasomotor function are needed.
Study limitations
A major study limitation is that only endothelium-inde-
pendent coronary vasodilation with NTG was evaluated.
Endothelium-dependent vasomotor function has been
shown to be an earlier marker of atherosclerosis and may
be more sensitive in patients with subclinical disease
[2,4,16]. Future studies should focus on overcoming the
challenges of performing a more endothelial-dependent
stimulus in the magnetic resonance environment. A pre-
liminary report [44] and a case report [45] on using the
cold pressor test show promise [44]. In addition, the size
of the clinical cohort was small and recruitment was con-
secutive, which may have contributed to the significant
differences in demographics (i.e., % female) between the
two groups. This difference did not account for the finding
of impaired vasodilation in the patients, as this finding
remained significant even when the only males were ana-
lyzed. A study incorporating more female patients is
needed to verify if the impaired coronary vasodilation
applies to high-risk women. Finally, long-term clinical
follow up is needed to determine the prognostic signifi-
cance of these findings.
Conclusion
NTG-induced coronary vasodilation assessed noninva-
sively by CMR was significantly impaired in asympto-
matic patients with DM and ESRD. This may provide an
additional functional measure of subclinical coronary
atherosclerosis in high-risk patients.
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